Single-center, Open, Non-randomized, Phase II Prospective Study of Apatinib Combined With Chemotherapy in the Treatment of Unresectable Soft Tissue Sarcoma
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Rivoceranib (Primary) ; Ifosfamide; Pirarubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
Most Recent Events
- 16 Oct 2019 New trial record